Search research articles
Contact Us
Filters
Showing results (1-10 of 525) with videos related to
Page
of 53
Sort By:
Breast Care (Basel, Switzerland)
|
November 16, 2010
Is Chemoendocrine Treatment without Alternative?
Richard Greil
Breast Care (Basel, Switzerland)
|
September 18, 2010
The Dark Side of the Moon - the Side Effects of Therapy in a Dynamic Era of Breast Cancer Management
Richard Greil
The New England Journal of Medicine
|
June 28, 2002
Monoclonal gammopathy of undetermined significance
Michael Fiegl, Richard Greil
Drug Metabolism Reviews
|
January 9, 2015
Digging deep into "dirty" drugs - modulation of the methylation machinery
Lisa Pleyer, Richard Greil
The Lancet. Oncology
|
March 3, 2007
Is it time to consider neoadjuvant treatment as the standard of care in oesophageal cancer?
Richard Greil, Hubert J Stein
Memo
|
December 19, 2017
ASCO-update: gastrointestinal tumors
Lukas Weiss, Florian Huemer, Richard Greil
Oncotarget
|
September 7, 2019
Mouse models to decipher anti-tumor immunity
Thomas Parigger, Richard Greil, Nadja Zaborsky
Expert Review of Anticancer Therapy
|
March 23, 2011
Zoledronic acid for adjuvant use in patients with breast cancer
Sigrun Ressler, Brigitte Mlineritsch, Richard Greil
Biomolecules
|
October 23, 2021
Recent Advances in Pancreatic Cancer: Novel Prognostic Biomarkers and Targeted Therapy-A Review of the Literature
Konstantin Schlick, Dominik Kiem, Richard Greil
The New England Journal of Medicine
|
July 5, 2013
Circulating tumor DNA to monitor metastatic breast cancer
Lukas Weiss, Clemens Hufnagl, Richard Greil
Page
of 53
Search research articles
Search
Showing results (1-10 of 525) with videos related to
Sort By:
Page
of 53
Breast Care (Basel, Switzerland)
|
November 16, 2010
Is Chemoendocrine Treatment without Alternative?
Richard Greil
Breast Care (Basel, Switzerland)
|
September 18, 2010
The Dark Side of the Moon - the Side Effects of Therapy in a Dynamic Era of Breast Cancer Management
Richard Greil
The New England Journal of Medicine
|
June 28, 2002
Monoclonal gammopathy of undetermined significance
Michael Fiegl, Richard Greil
Drug Metabolism Reviews
|
January 9, 2015
Digging deep into "dirty" drugs - modulation of the methylation machinery
Lisa Pleyer, Richard Greil
The Lancet. Oncology
|
March 3, 2007
Is it time to consider neoadjuvant treatment as the standard of care in oesophageal cancer?
Richard Greil, Hubert J Stein
Memo
|
December 19, 2017
ASCO-update: gastrointestinal tumors
Lukas Weiss, Florian Huemer, Richard Greil
Oncotarget
|
September 7, 2019
Mouse models to decipher anti-tumor immunity
Thomas Parigger, Richard Greil, Nadja Zaborsky
Expert Review of Anticancer Therapy
|
March 23, 2011
Zoledronic acid for adjuvant use in patients with breast cancer
Sigrun Ressler, Brigitte Mlineritsch, Richard Greil
Biomolecules
|
October 23, 2021
Recent Advances in Pancreatic Cancer: Novel Prognostic Biomarkers and Targeted Therapy-A Review of the Literature
Konstantin Schlick, Dominik Kiem, Richard Greil
The New England Journal of Medicine
|
July 5, 2013
Circulating tumor DNA to monitor metastatic breast cancer
Lukas Weiss, Clemens Hufnagl, Richard Greil
Page
of 53